That might be a little light. But $15.00 might get me interested.
Yeah, agreed…something is not going well. Do you think the prospective drug candidates have any chance of truly being approved ?
This stock should be in the mid teens based on the pipeline alone. The positive news at ASCO should have bumped it even more.
Other biotech's seem to run up on very little, if any real data…even in phase 1 and early phase 2. Array can't seem to get back to 4 much less 5 ?
Basically this has become a failure of a company…can't impress wall street no matter what.
They could actually find a cure for cancer…the stock would still trade a $3.75 because wall street expects it to.